Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
In Amgen Inc. v. Hospira, Inc., the Federal Circuit held that Amgen could not obtain discovery related to activities that might infringe a patent that it had not asserted in its biosimilar patent litigation against Hospira....more